Published in Gene Therapy Weekly, April 6th, 1998
An attractive alternative to protein- or peptide-based immunization approaches involves the use of DCs in a DNA-based strategy. Thomas Tuting and a research team from several institutions evaluated the feasibility of DNA vaccination for the induction of cytotoxic T cell (CTL) reactivity to five different melanoma antigens (Ags) in vitro ("Autologous Human Monocyte-Derived Dendritic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly